The Company presents basic and diluted earnings per share ("EPS") data for its common stock.
These receivables typically have terms from two to seven years.
â€¢Subscriptions to third party content revenue is recognized as a separate performance obligation ratably over the subscription term based on SSP, which is cost plus a reasonable margin.
Total rent expense for the three months ended March 31, 2019 and 2018 was $0.6 million and $0.7 million, respectively.
The Company grants restricted stock to executive officers, certain key employees and non-employee directors under the Plans with the fair value of the awards representing the fair value of the common stock on the date the restricted stock is granted.
Payment is due monthly as services are performed.
Our CODM group is comprised of the Chief Executive Officer, Chief Growth Officer, Chief Operating Officer, and Chief Financial Officer.
Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements.Lastly, stock compensation expense increased $0.3 million as a result of additional grants of stock made during the trailing twelve months.
Acute Care EHR bookings in the first quarter 2019 decreased by $9.2 million, or 53%, from the first quarter 2018, mostly as net new installation bookings have been severely impaired by a lack of urgency on the part of prospective customers, resulting in a low volume of decisions for new system implementations.
In conjunction with our acquisition of HHI in January 2016, we entered into the Previous Credit Agreement which provided for the $125 million Previous Term Loan Facility and the $50 million Previous Revolving Credit Facility.
As a result, retention of existing EHR customers is a key component of our long-term growth strategy by protecting this base of potential cross-sell customers, while at the same time serving as a leading indicator of our market position and stability of revenues and cash flows.
Unlike our perpetual license arrangements under which the related revenue is recognized effectively upon installation, the SaaS arrangements result in revenue being recognized monthly as the services are provided over the term of the arrangement.
As of March 31, 2019, our principal sources of liquidity consisted of cash and cash equivalents of $4.4 million and our remaining borrowing capacity under the Amended Revolving Credit Facility of $20.3 million, compared to $5.7 million of cash and cash equivalents and $20.3 million of remaining borrowing capacity under the Amended Revolving Credit Facility as of December 31, 2018.
Our companies currently support approximately 1,000 acute care facilities and approximately 3,300 post-acute care facilities with a geographically diverse customer mix within the domestic community healthcare market.
Net cash used in investing activities increased with $0.5 million used in the three months ended March 31, 2019 compared to $0.1 million used during the three months ended March 31, 2018.
As such, maintaining and growing recurring revenues are additional key components of our long-term growth strategy, aided by the aforementioned focus on customer retention, and include a renewed focus on driving demand for subscriptions for our existing technology solutions.None.